Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
2.140
-0.120 (-5.31%)
Dec 5, 2025, 4:00 PM EST - Market closed
APUS Market Cap
APUS has a market cap or net worth of $26.91 million as of December 5, 2025.
Market Cap
26.91M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since the IPO on December 2, 2025, APUS's market cap has decreased from $27.67M to $26.91M, a decrease of -2.73%. That is a compound annual growth rate of -99.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 28.42M | 3.67% |
| Dec 3, 2025 | 27.42M | -0.91% |
| Dec 2, 2025 | 27.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.09B |
| Johnson & Johnson | 487.35B |
| AbbVie | 400.38B |
| UnitedHealth Group | 299.62B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.73B |
| Merck & Co. | 248.38B |
| Abbott Laboratories | 217.85B |